Indeed, the present research is focused on the understanding of the molecular mechanisms favoring cancer development in obese patients, as well as the underlying pathways that unleash the inflammatory state, characterized by high levels of cytokines and adipokines (IL-1, IL-6, TNF-α, leptin) and CRP, and lower concentrations of circulating APN. The gene discussed is IL1B; the disease is cancer.